The aim of this article was to determine whether CSF PDGFRβ is indeed associated with aging and key AD pathologic changes (measured with Aβ-PET and tau-PET) and APOE ε4 genotype in the deeply phenotyped BioFINDER-2 cohort. The gene discussed is MAPT; the disease is Alzheimer disease.